Antigenics, Inc. (NASDAQ:AGEN)

CAPS Rating: 2 out of 5

A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.

Recs

0
Player Avatar poconobear (97.09) Submitted: 7/25/2009 7:48:51 AM : Outperform Start Price: $13.80 AGEN Score: -98.79

biotech spec

Featured Broker Partners


Advertisement